Marwa Elnahas/LinkedIn
Apr 15, 2026, 12:44
Marwa Elnahas: 4Ts Scoring Tool for Heparin – Induced Thrombocytopenia
Marwa Elnahas, Senior Neonatal and Pediatric Clinical Pharmacist, Clinical pharmacy trainer at Ministry of Health and Population – Egypt, shared a post on LinkedIn:
“4Ts scoring tool for heparin-induced thrombocytopenia (HIT)
A validated, widely used clinical pretest probability tool.
It helps the physician whether to order urgent diagnostic lab tests and whether to switch to alternative anticoagulation, thereby reducing overtesting and overdiagnosis.
4Ts stands for:
- ‘T’ hrombocytopenia (Magnitude) of The severity.
- ‘T’ iming of Platelet Count Fall.
- ‘T’ hrombosis.
- ‘T’ hrombocytopenia: Whether other reasons for a low platelet count are apparent.
Interpretation:
- Low Risk (0 – 3 points): HIT is unlikely (lower 2% risk).
- Intermediate Risk (4 – 5 points): Intermediate probability.
- High Risk (6 – 8 points): High probability (~64% risk)”
Stay updated with Hemostasis Today.
-
May 30, 2026, 18:12Khokon Miah Akanda: FDA Approves a First-in-Class Hypertension Drug
-
May 30, 2026, 18:11Alessandro Perrella: It is Not Only about “How High the CRP is”, but “in Which Patient” We are Measuring That Value
-
May 30, 2026, 18:11Jasper van Grunsven: Grateful for Our Rare Disease Team and the Commitment That Drives Our Mission
-
May 30, 2026, 18:10Open Registration for the 2026 Thrombosis Canada Annual Education Conference – Thrombosis Canada
-
May 30, 2026, 18:09Peter Zdziarski: Approval Does Not Mean NovoSeven is 100% Effective or Risk-Free in GT
-
May 30, 2026, 17:07Deepak Yadav: A Privilege to Talk on ESUS at CREST Stroke Conclave 2026
-
May 30, 2026, 16:59Syed A Rizvi: Medical Scoring Systems – Small Numbers, Big Clinical Decisions
-
May 30, 2026, 16:53Timothy “Tim” Sheehan: BNY Wealth Joins the Fight Against Blood Disorders In Support of Hemophilia of Georgia
-
May 30, 2026, 16:51Nouf Bahri: Anticoagulation Initiation for New-Onset Atrial Fibrillation in Critical Illness